Back to results
US 11,993,613 B2Granted
Thiazolo[5,4-b]pyridine MALT-1 inhibitors
AssigneeAbbVie Inc.
InventorsPuneet Kumar, Anthony Mastracchio, Mark Mills, Andrew William Phillips
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for compounds of the general Formula (I) wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof.
Claims2
N-{(1S)-1-[4-({7-[(1R)-2,2-difluoro-1-methoxyethyl]-2-methyl[1,3]thiazolo[5,4-b]pyridin-6-yl}amino)phenyl]-2,2,2-trifluoroethyl}-N-methyl-1,1-dioxo-1λ6-thiane-4-carboxamide;
- or a pharmaceutically acceptable salt thereof.
N-{(1S)-1-[4-({7-[(1R)-2,2-difluoro-1-methoxyethyl]-2-methyl[1,3]thiazolo[5,4-b]pyridin-6-yl}amino)phenyl]-2,2,2-trifluoroethyl}-N-methyl-1,1-dioxo-1λ6-thiane-4-carboxamide.
Dependencies are inferred from the claim text.